Showing posts with label Breast Cancer. Show all posts
Showing posts with label Breast Cancer. Show all posts

Tuesday, September 11, 2007

Researchers Seeking More Minority Women for "Sister Study" on Breast Cancer Risk

Researchers of a large breast cancer study of sisters are encouraging more minority women to enroll to ensure a diverse study sample and far-reaching results. The National Institute of Environmental Health Sciences (NIEHS) plans to enroll 50,000 women in its Sister Study by the end of 2007. The study's purpose is to study breast cancer risk factors in sisters of women diagnosed with breast cancer. As of August 7, 2007, 39,176 women had enrolled in the study, 12% of whom represent minorities.

"During 2007, our last recruitment year, we are urgently requesting each of you or your organization to help us get 5 to 50 women to enroll in the study," the Sister Study website stated.

The largest study of its kind to study breast cancer risk factors, the Sister Study will follow participants for 10 years. Women who develop breast cancer will be compared with those who do not. At the onset of the study, participants will be asked to complete several questionnaires and provide a sample of their blood, urine, toenails, and household dust.

Currently, the Sister Study has enrolled:
2,531 African American sisters
463 American Indian sisters
335 Asian sisters
1,300 Latina sisters
5,329 senior sisters aged 65-74

By studying women who have similar genes and often share similar environments, researchers hope to gain insight into the causes of breast cancer. Women who meet the following requirements may be eligible to enroll in the Sister Study:
Be between 35 and 74 years of age
Live in the United States
Have no personal history of breast cancer Have a sister (living or deceased) who has had breast cancer

According to the Sister Study website, "through a range of questionnaires and samples from the participants, the 10-year study will take a detailed look at how women's genes, and things women come in contact with at home, at work, and in the community may influence breast cancer risk."

Women who enroll in the Sister Study will be mailed a study kit that contains study information, questionnaires, and material to use when collecting urine, toenail, and household dust samples. In addition, women will be required to participate in a visit by a female health professional during which time a blood test and other various tests will be administered. Paper questionnaires and a telephone interview are also required.

Additional Resources and References
Imaginis.com provides additional information about the Sister Study at http://www.imaginis.com/breasthealth/sister_study.asp
To volunteer or learn more about the Sister Study, please visit http://www.sisterstudy.org/ or call 1.877.4SISTER (1.877.474.7837). Deaf/Hard of Hearing call 1.866.TTY.4SIS (1.866.889.4747)

Saturday, August 18, 2007

Racial Disparities In Breast Cancer Survival Persist

Racial differences in breast cancer survival increase according to stage of disease, a new study finds. Published in the September 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, a retrospective analysis of survival data demonstrates that within each stage, African American women had larger tumors and were more likely to have disease that had spread to nearby lymph nodes. After controlling for those clinical factors the racial disparities in survival persisted. The investigators say their finding that disparities in survival increased with more advanced disease was surprising and suggested that non-clinical factors contributed to survival differences.

Epidemiology studies have long showed significant racial/ethnic differences in breast cancer survival among U.S. women. African American women have poorer five-year survival rates, and more advanced disease at the time of diagnosis than white women. Whether these disparities are due to a difference between races in tumor biology or to socioeconomic factors that impact healthcare access and/or the physician-patient relationship continues to be unclear.

One key piece of evidence is that, stage for stage, African American women have worse clinical outcomes than white women. However, staging disease is complex, taking into account tumor size and regional or distant disease spread. Also, there can be significant differences in survival within each stage. For example, survival at the same stage can vary by 40 percent depending on the number of lymph nodes with disease.

Dr. Alfred Neugut from Columbia University Medical Center, Russell McBride from Mailman School of Public Health and their colleagues hypothesized that racial differences in survival within stage could be attributed to differences in tumor size and the number of lymph nodes with disease between the two race groups.

Analysis of clinical and demographic characteristics from 256,174 women with breast cancer (21,861 African American and 234,313 white) diagnosed from 1988-2003 showed that African American women were more likely than white women to be diagnosed with tumors greater than 2.0-cm and to have at least one lymph node with disease. However, racial differences in lymph node involvement were apparent only in tumors smaller than 3.0 cm.

After adjusting for tumor size and lymph node status as well as other known factors, such as age, African American women were still more likely to die from their disease. The mortality rate among African American women was calculated to be up to 56 percent higher than whites.

This study confirms 'statistically significant differences within stage between black and white women in tumor size and nodal involvement.' However, the authors conclude, "these differences are not clinically important with respect to survival over and above the standard AJCC stage categories."

The study also found that as stage of disease at diagnosis increases, so too does the gap in mortality between African American and white women. The authors postulate that 'the factors that prevent black women from receiving the same quality of care as white women may be exacerbated by the more complex treatment regimens used for more advanced breast cancer.'

By Article: "Within-Stage Racial Differences in Tumor Size and Number of Positive Lymph Nodes in Women With Breast Cancer," Russell McBride, Dawn Hershman, Wei-Yann Tsai, Judith S. Jacobson, Victor Grann, Alfred I. Neugut, CANCER; Published Online: August 13, 2007

Thursday, August 16, 2007

Breast Cancer Prevention Practices Vary Across Canada

Breast cancer preventive practices for Canadian women carrying the cancer gene vary across the country, says University of Toronto research, and many women are not taking advantage of the options available.

The study, published in the journal Open Medicine, followed the experiences of Canadian women with a BRCA1 or BRCA2 mutation a genetic mutation that predisposes them to a 87 per cent lifetime risk of developing breast cancer. Women carrying the gene have several options for cancer prevention including prophylactic surgery, chemoprevention and screening; however, researchers observed significant differences across Canada in the uptake of these preventions, with women in Quebec the least likely to use preventive measures.

"We were very surprised by the discrepancy in preventative measures taken across the country," says Professor Kelly Metcalfe, Lawrence Bloomberg Faculty of Nursing, lead author of the study. "The benefit of genetic testing is that we can identify women at high risk of developing breast cancer and hopefully reduce that risk. Ultimately though, women have to elect to undertake one of the options."

In the study, 672 Canadian women were identified as carrying the genetic mutation. Followup questionnaires were completed after a mean of four years. Out of the 342 women without breast cancer after four years, 157 (46 per cent) had not undertaken any cancer prevention option such as a mastectomy, oophorectomy or tamoxifen or raloxifene drugs used in chemoprevention. Broken down geographically, 39 per cent of women with the genetic mutation in Ontario did not take preventive measures; 34 per cent in Western Canada and 62 per cent in Quebec.

"The numbers show a huge discrepancy, with women in Quebec being the least likely to elect for a preventive option," Metcalfe says. "This will have significant implications in terms of the numbers of cancers we see developing in this high-risk group. We still need to do more research to explain why these differences exist."

University of Toronto

Monday, July 16, 2007

Breast Cancer And Aspirin

A new study suggests that aspirin may lower the risk of breast cancer.

Only one out of five women with breast cancer--versus one out of four without the disease--reported having taken aspirin at least once a week for six months or more. That translates into a 20 percent lower risk for the aspirin takers. Women who took aspirin at least seven times a week had a 30 percent lower risk. (The researchers didn't ask how much aspirin the women took each time.)

Ibuprofen (Advil, Motrin) had a weaker impact on risk, but the study had few ibuprofen takers. However, a study last fall found a 20 percent lower risk of breast cancer among women who took ibuprofen at least twice a week for five to nine years, and a 50 percent lower risk in those who took it for ten years. It also found a 20 percent lower risk in women who took 100 mg or more of aspirin at least twice a week for five to ten years. Regular use of acetaminophen (Tylenol) or low-dose aspirin (less than 100 mg) had no impact on breast cancer risk.

What to do: Talk to your doctor about whether to take aspirin or ibuprofen regularly. Both drugs can cause gastrointestinal bleeding and peptic ulcer disease.

J. Amer. Med. Assoc. 291: 2433, 2488, 2004 and Cancer Research 63: 6096, 2003.
Nutrition Action Healthletter

Friday, June 29, 2007

Breast Cancer: Steps To Aid In Early Detection

I learned some interesting facts about breast cancer that I feel every woman should know. The sources I used for this article included the American Cancer Society, The National Cancer Institute, and the Avon Foundation’s Breast Cancer Crusade.

Early breast cancer isn’t usually detected by pain. In fact, when breast cancer first develops, there may be no symptoms at all. That is why regular exams are important. If you have anything that makes you suspect breast cancer, contact your doctor immediately. Don't wait around to see what happens. Let the professional decide. Some symptoms that may indicate breast cancer include, but are not limited to, the following:


Nipple discharge or tenderness

Lumps in breast and/or underarm area

Visual changes which include: size of breast including swelling; inverted nipple; and pitting. Pitting means the skin looks like the skin of an orange. Scaling of the breast skin could also be a symptom.

Early detection of breast cancer is important. There is a 97% five-year survival rate when breast cancer is detected early since this can help prevent it from spreading. Below are some guidelines to early detection. I hope they help save someone's life.

Get a Mammogram

A mammogram is a specialized x-ray of the breast to help detect cancers which cannot be detected by feel. Some women are confused as to how often they should get a mammogram. Here is what the professionals say about mammograms.

At age 40 begin getting annual mammograms by a licensed technician. A mammogram will take about twenty minutes. When getting a mammogram avoid wearing deodorant, powders, or cream under your arms. Sometimes they can interfere with the results. Make sure to contact the center if they do not inform you of the results within thirty days. It is very important that results are compared from one year to the next. Hence, be sure you know where your mammogram film is being held.

Clinical Breast Exam

This is an exam by a health care professional. Women in their 20s and 30s should have a clinical breast exam at least every three years and women 40 or older should have an exam each year.

Self-Examination

Starting at age 20 women should begin doing a self-exam. Ask your doctor if you are not exactly sure how to do this or if you are not sure you are doing it correctly. Here are a few guides to follow: Lie down and place one arm behind your head. Using your three middle finger pads press firmly across your breast in overlapping dime-size circular motions. Use three different levels of pressure: light, medium, and firm. This allows you to feel the tissue close to your skin, to feel a little deeper, and to feel the tissue closest to your chest and ribs.

Move across your breast in an up and down pattern, starting from the underarm and moving across the breast to the middle of the chest bone, repeating the pressure.

Stand in front of a mirror with your hands pressing down on your hips and look at your breasts for any changes in size, shape, contour, or dimpling. Also, do this with your arms slightly raised. Make sure you check under your breasts as well.

I hope that this information proves helpful to you. I am not a health care provider and by no means a professional on breast cancer. I am simply sharing with every woman possible the importance of detecting breast cancer early and some simple guidelines that might save a life.

My sources for the above information are:

American Cancer Society The National Cancer Institute Breast Health Resource Guide by the Avon Foundation's Breast Cancer Crusade

By: Donna Rivera-Loudon

Thursday, June 28, 2007

New Cancer Worries For Diet Soda Drinkers

A new study on the effects of low daily doses of the artificial sweetener aspartame shows a statistically significant increase in leukemia, lymphoma and breast cancer in rats. Consumer advocates are calling for the FDA to take another look at the safety of aspartame in light of the study, but the FDA seems uninterested.
"Because aspartame is so widely consumed, it is urgent that the FDA evaluate whether aspartame still poses a 'reasonable certainty of no harm,' the standard used for gauging the safety of food additives," said CSPI executive director Michael F. Jacobson. "But consumers, particularly parents, shouldn't wait for the FDA to act. People shouldn't panic, but they should stop buying beverages and foods containing aspartame."
The study, which can be read here, followed a group of 4,000 rats who were given low daily doses of aspartame (comparable to what a dedicated human diet soda drinker might consume, were he/she a rat) beginning during "prenatal" life. The rats were dissected after natural death and the effects of the aspartame calculated. From the study:
The results of this carcinogenicity bioassay not only confirm, but also reinforce the first experimental demonstration of APM's multipotential carcinogenicity at a dose level close to the acceptable daily intake (ADI) for humans. Furthermore, the study demonstrates that when lifespan exposure to [aspartame] begins during fetal life, its carcinogenic effects are increased
The authors of the study claim that current research on the effects of aspartame are based on studies that did not use a large enough sample of animals and did not allow the animals to live out their natural lifespan.The authors also took issue with a study conducted by the US National Institutes of Health and the American Association of Retired Persons, in which a number of Americans responded to self-administered questionnaires about what they ate and the results compared to their rate of brain cancer.

The FDA responded to the CSPI in an email to Reuters, claiming not to have reviewed the study:
"However, the conclusions from this second European Ramazzini Foundation are not consistent with those from the large number of studies on aspartame that have been evaluated by FDA, including five previously conducted negative chronic carcinogenicity studies," Herndon said in an e-mail.

"Therefore, at this time, FDA finds no reason to alter its previous conclusion that aspartame is safe as a general purpose sweetener in food."
The CSPI has downgraded aspartame to "everyone should avoid," and recommends choosing drinks that contain Splenda instead. CSPI regards Splenda as safe. If you drink a lot of aspartame, or you have kids who do, you might want to read the study and decide for yourself.

By: Consumerist.com

Tennis Mom Betty Agassi On Her Breast Cancer Journey

Americans' risk of getting and dying from cancer continues to decline and survival rates for many cancers continue to improve, according to the American Cancer Society. That's encouraging news for those who are cancer-free, as well as the more than 10 million Americans living as cancer survivors.

In fact, the largest group of cancer survivors is breast cancer patients, who represent approximately 20 percent of all cancer survivors. Early detection and more treatment options have contributed significantly to these improved statistics.

But even for those living with breast cancer and celebrating survivorship-more than 2 million women in the United States-prevention of recurrent breast cancer is a critical priority. Breast cancer may not just come back in the breast: It can come back in other tissues and organs such as the stomach, brain and liver. Now more than ever, breast cancer patients are not only celebrating life, but focusing their attention on becoming champions of their own health.

In 2000, Betty Agassi, mother of world tennis champion Andre Agassi, was diagnosed with breast cancer. Now six years after her breast cancer diagnosis, Mrs. Agassi focuses her energy on encouraging other breast cancer survivors to stay on top of their health and get informed about advances in the disease. As part of this commitment, Mrs. Agassi partnered with Novartis to launch an education initiative at the U.S. Open in 2006-Andre Agassi's last as a professional tennis player.

"I want women to get as much information as they can about what's new in breast cancer. Speak to your doctor; find out what new and existing treatment options are available and ask the right questions to help minimize the risk of your breast cancer returning."

Through this initiative, Mrs. Agassi is directing women and their families to www.ribbonofpink.com, a Web site that provides information about progress in breast cancer treatment and tips for healthy living, which may help women to protect themselves after their surgery.

Mrs. Agassi recently sat down to discuss her own journey with breast cancer and her personal mission of educating other women with breast cancer on ways to reduce breast cancer recurrence.

Question: Obviously, this is a personal cause, one that lies close to your heart. Can you tell us more about your own experience?

Betty Agassi: In 2000, when my doctor told me I had breast cancer, I was truly devastated. Now, six years later, I feel great and have a good prognosis. But, that said, I know that there is a possibility of my breast cancer coming back. I'm lucky to have the support of my family, in particular, but I do understand that working to prevent breast cancer recurrence is part of my everyday life. Part of my journey and the reason I'm doing this is that I'd like to make sure that other women do the same.

Q: What is your most urgent message?

BA: Never stop learning, never stop questioning your doctor and never lose hope. It really is so important for women to understand that the breast cancer journey does not stop after initial treatment. I would think that any woman who has been diagnosed with breast cancer and gone through her treatment regimen would want to take any necessary precautions to make sure the cancer does not return.

Q: If you could offer three tips to those doing everything they can to minimize the chances of their breast cancer coming back, what would they be?

BA: Knowledge, communication and support are the keys to staying on top of your health and minimizing the chances of your breast cancer coming back. Staying informed about new and existing treatment options and knowing which options you may be a candidate for are vital. So, communicate with your doctor.

By: Stacey Moore